N-methyl-Daspartate receptor (NMDAR) antagonists, such as phencyclidine (PCP), ketamine and dizocilpine (MK801), have been widely used for inducing schizophrenia animal models. As a noncompetitive selective NMDAR antagonist, MK801 has two stereoisomers, (+)MK801 and (-)MK801, which have been found to induce different behavioral phenotypes and histological changes in animals. In this study, we compared differential effects of (+)MK801 and (-)MK801 on brain structure and metabolism in adolescence rats with MRI/in vivo 1H-MRS. The results showed that (+)MK801 induced more severe gray matter (GM) atrophy and more evident metabolic changes than (-)MK801, and the different effects were related to their potency at NMDA receptors.
This abstract and the presentation materials are available to members only; a login is required.